Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor

Virology

Volumn 229, Issue 2, 1997, Pages 421-428

  Yang, Wei Xing ^a   Terasaki, Tetsuya ^a   Shiroki, Kazuko ^a   Ohka, Seii ^a   Aoki, Junken ^a   Tanabe, Shuichi ^a   Nomura, Tatsuji ^b   Terada, Eiji ^c   Sugiyama, Yuichi ^a   Nomoto, Akio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS TRANSMISSION;

ANIMALIA; MUS MUSCULUS; POLIOVIRUS;

EID: 0031575747     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8450     Document Type: Article

References (33)

1. Abe S., Ota Y., Koike S., Kurata T., Horie H., Nomura T., Hashizume S., Nomoto A. Neurovirulence tests for oral live poliovaccines using poliovirus-sensitive transgenic mice. Virology. 206:1995a;1075-1083.
2. Abe S., Ota Y., Doi Y., Nomoto A., Nomura T., Chumakov K. M., Hashizume S. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus. Virology. 210:1995b;160-166.
3. Aoki J., Koike S., Ise I., Sato-Yoshida Y., Nomoto A. Amino acid residues on human poliovirus receptor involved in interaction with poliovirus. J. Biol. Chem. 269:1994;8431-8438.
4. Bodian D. Emerging concept of poliomyelitis infection. Science. 122:1955;105-108.
5. Finny D. J. The design and analysis of an immunological assay. Acta Microbiol. Hung. VI:1959;341-368.
6. Freistadt M. S., Eberle K. E. Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence. J. Virol. 70:1996;6486-6492.
7. Hickey W. F., Hsu B. L., Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28:1991;254-260.
8. Hogle J. M., Chow M., Filman D. J. Three-dimensional structure of poliovirus at 2.9 ångstrom resolution. Science. 229:1985;1358-1363.
9. Horie H., Koike S., Kurata T., Sato-Yoshida Y., Ise I., Ota Y., Abe S., Hioki K., Kato H., Taya C., Nomura T., Hashizume S., Yonekawa H., Nomoto A. Transgenic mice carrying the human poliovirus receptor: new animal model for study of poliovirus neurovirulence. J. Virol. 68:1994;681-688.
10. Kajigaya S., Arakawa H., Kuge S., Koi T., Imura N., Nomoto A. Isolation and characterization of defective-interfering particles of poliovirus Sabin 1 strain. Virology. 142:1985;307-316.
11. Kakee A., Terasaki T., Sugiyama Y. Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier. J. Pharmacol. Exp. Ther. 277:1996;1550-1559.
12. Kitamura N., Semler B. L., Rothberg P. G., Larsen G. R., Adler C. J., Dorner A. J., Emini E. A., Hanecak R., Lee J. J., van der Werf S., Anderson C. W., Wimmer E. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature. 291:1981;547-553.
13. Kohara M., Abe S., Komatsu T., Tago K., Arita M., Nomoto A. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. J. Virol. 62:1988;2828-2835.
14. Koike S., Taya C., Aoki J., Matsuda Y., Ise I., Takeda H., Matsuzaki T., Amanuma H., Yonekawa H., Nomoto A. Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene: influence of the transgene expression on pathogenesis. Arch. Virol. 139:1994a;351-363.
15. Koike S., Taya C., Kurata T., Abe S., Ise I., Yonekawa H., Nomoto A. Transgenic mice susceptible to poliovirus. Proc. Natl. Acad. Sci. USA. 88:1991;951-955.
16. Koike S., Horie H., Ise I., Okitsu A., Yoshida M., Iizuka N., Takeuchi K., Takegami T., Nomoto A. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 9:1990;3217-3224.
17. Koike S., Aoki J., Nomoto A. Transgenic mouse for the study of poliovirus pathogenicity. Cellular Receptors for Animal Viruses. 1994b;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 463-480.
18. Li T., Zang A., Iizuka N., Nomoto A., Arnold E. Crystallization and preliminary X-ray diffraction studies of coxsackievirus B1. J. Mol. Biol. 223:1992;1171-1175.
19. Mendelsohn C. L., Wimmer E., Racaniello V. R. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell. 56:1989;855-865.
20. Nomoto A., Koike S., Aoki J. Tissue tropism and species specificity of poliovirus infection. Trends in Microbiol. 2:1994;47-51.
21. Omata T., Kohara M., Kuge S., Komatsu T., Abe S., Semler B. L., Kameda A., Itoh H., Arita M., Wimmer E., Nomoto A. Genetic analysis of the attenuation phenotype of poliovirus type 1. J. Virol. 58:1986;348-358.
22. Pardridge W. M., Triguero D., Buciak J., Yang J. Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector. J. Pharmacol. Exp. Ther. 255:1990;893-899.
23. Pardridge W. M., Buciak J. L., Friden P. M. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. J. Pharmacol. Exp. Ther. 259:1991;66-70.
24. Racaniello V. R., Baltimore D. Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc. Natl. Acad. Sci. USA. 78:1981;4887-4891.
25. Ren R., Costantini F., Gorgacz E. J., Lee J. J., Racaniello V. R. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell. 63:1990;353-362.
26. Ren R., Racaniello V. R. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J. Virol. 66:1992a;296-304.
27. Ren R., Racaniello V. R. Poliovirus spreads from muscle to the central nervous system by neural pathways. J. Infect. Dis. 166:1992b;747-752.
28. Sabin A. B. Pathogenesis of poliomyelitis: Reappraisal in the light of new data. Science. 123:1956;1151-1157.
29. Sabin A. B., Boulger L. R. History of Sabin attenuated poliovirus oral live vaccine strains. J. Biol. Stand. 1:1973;115-118.
30. Shiroki K., Ishii T., Aoki T., Kobashi M., Ohka S., Nomoto A. A new cis-acting element for RNA replication within the 5′ noncoding region of poliovirus type 1 RNA. J. Virol. 69:1995;6825-6832.
31. Smith Q. R., Momma S., Aoyagi M., Rapoport S. I. Kinetics of neural amino acid transport across the blood-brain barrier. J. Neurochem. 49:1987;1651-1658.
32. Terasaki T., Iga T., Sugiyama Y., Hanano M. Pharmacokinetic study on the mechanism of tissue distribution of dexorubicin: interorgan and interspecies variation of tissue-to-plasma partition coefficients in rats, rabbits, and guinea pigs. J. Pharm. Sci. 73:1984;1359-1363.
33. Triguero D., Buciak J., Pardridge W. M. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J. Neurochem. 54:1990;1882-1888.